Abstract
A 27-year-old woman with colon cancer and liver metastasis was referred to our hospital. Colectomy and colostomy were performed to improve her ileus. Following 13 sessions of oxaliplatin-based chemotherapy (OC) with mFOLFOX6 + bevacizumab, thrombocytopenia and frequent peristomal bleeding occurred. Computed tomography showed severe ascites, splenomegaly, significant collateral veins around the stoma, and severe stenosis of the hepatic veins (HV) and inferior vena cava (IVC). Ultrasound elastography showed high liver (and spleen) stiffness values. Repeated OC appeared to cause IVC stenosis as a result of worsening sinusoidal obstruction syndrome (SOS), and peristomal variceal bleeding. After ultrasound-guided percutaneous embolization, bleeding did not recur. Unfortunately, the patient died of liver dysfunction caused by severe SOS. The incidence of OC-induced SOS is reported to be about 50%; however, there is apparently no report of OC-induced HV and IVC stenosis, and in most cases, portal hypertension is improved after OC cessation. This is the first report of OC-induced severe HV and IVC stenosis resulting in refractory peristomal variceal bleeding and eventual death.
Similar content being viewed by others
Abbreviations
- OC:
-
Oxaliplatin-based chemotherapy
- HV:
-
Hepatic veins
- IVC:
-
Inferior vena cava
- SOS:
-
Sinusoidal obstruction syndrome
- CT:
-
Computed tomography
- GVHD:
-
Graft versus host disease
- US:
-
Ultrasound
- MMP:
-
Matrix metalloproteinase
- VEGF:
-
Vascular endothelial growth factor
- BCS:
-
Budd–Chiari syndrome
- RHV:
-
Right hepatic vein
References
de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938–47.
Rubbia-Brandt L, Lauwers GY, Wang H, et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology. 2010;56:430–9.
Soubrane O, Brouquet A, Zalinski S, et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg. 2010;251:454–60.
Narita M, Oussoultzoglou E, Chenard MP, et al. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization. Ann Surg Oncol. 2012;19:2230–7.
van den Broek MA, Vreuls CP, Winstanley A, et al. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases. Ann Surg Oncol. 2013;20:1462–9.
Vreuls CP, Driessen A, Olde Damink SW, et al. Sinusoidal obstruction syndrome (SOS): a light and electron microscopy study in human liver. Micron. 2016;84:17–22.
Zhou H, Wang YX, Lou HY, et al. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features. Korean J Radiol. 2014;15:218–25.
Erturk SM, Mortelé KJ, Binkert CA, et al. CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. Am J Roentgenol. 2006;186:1497–501.
Ribero D, Wang H, Donadon M, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer. 2007;110:2761–7.
Deleve LD, Wang X, Tsai J, et al. Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology. 2003;125:882–90.
Hubert C, Sempoux C, Humblet Y, et al. Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab. HPB (Oxford). 2013;15:858–64.
Bloor K, Orr W. A case of hemorrhage from varices in the small intestine due to portal hypertension. Br J Surg. 1961;48:423–4.
Mukund A, Pargewar SS, Desai SN, et al. Changes in liver congestion in patients with Budd–Chiari syndrome following endovascular interventions: assessment with transient elastography. J Vasc Interv Radiol. 2017;28:683–687.
Colli A, Pozzoni P, Berzuini A, et al. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology. 2010;257:872–8.
Taniguchi T, Sakata Y, Ohtani T, et al. Usefulness of transient elastography for noninvasive and reliable estimation of right-sided filling pressure in heart failure. Am J Cardiol. 2014;113:552.
Jalal Z, Iriart X, De Lédinghen V, et al. Liver stiffness measurements for evaluation of central venous pressure in congenital heart diseases. Heart. 2015;101:1499–504.
Miura K, Nakano H, Sakurai J, et al. Splenomegaly in FOLFOX-naïve stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy. Int J Clin Oncol. 2011;16:257–63.
Imai K, Emi Y, Iyama KI, et al. Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome. Eur J Surg Oncol. 2014;40:559–66.
Furuichi Y, Moriyasu F, Taira J, et al. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol. 2013;48:1061–8.
Acknowledgements
We thank Dr. Edward Barroga (http://orcid.org/0000-0002-8920-2607), Associate Professor and Senior Medical Editor from the Department of International Medical Communications of Tokyo Medical University for reviewing and editing the manuscript. This case report was partly supported by a Health Labour Sciences Research Grant from Research on Measures for Intractable Diseases and the Intractable Hepato-Biliary Diseases Study Group in Japan.
Author information
Authors and Affiliations
Contributions
HY (drafting of the manuscript, literature search, data collection, figures, performing chemotherapy and endoscopy); YF (drafting the manuscript, figures, table, data interpretation, concept design, performing IVR); YK (CT images and data collection); HT and YY (performing IVR, exploration of medical record); KS and IN (literature search, performing ultrasonography); TI (concept design)
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Financial support
This study was partly supported by a Health and Labour Sciences Research Grant from the Japanese Ministry of Health, Labour and Welfare for Research on Intractable Diseases and Portal Hemodynamic Abnormalities.
Human rights
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Rights and permissions
About this article
Cite this article
Yamaguchi, H., Furuichi, Y., Kasai, Y. et al. A case of severe stenosis of hepatic veins and inferior vena cava with stomal variceal bleeding induced by oxaliplatin-based chemotherapy. Clin J Gastroenterol 11, 150–155 (2018). https://doi.org/10.1007/s12328-017-0814-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-017-0814-4